New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability
STAT's Morning Rounds reports a planned trial that will test weekly semaglutide injections in people with alcohol use disorder, opioid use disorder, or both, tracking criminal justice involvement, employment, housing stability and health care use. Run by the Center for Addiction Science, Policy and Research and Allegheny County's Department of Human Services, it is set to begin in early 2027, enrolling up to 1,200 participants.
Why it matters: Relevant to clinicians who treat or refer patients with alcohol or opioid use disorder, and to readers following research on GLP-1 weight-loss drugs.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to statnews.com. October 14, 2026.
